Want to see RVP full AI Analyst Report?
Top Page
Retractable Technologies
(RVP)
Select Model
Select Model
Rating:48Neutral
Price Target:
$0.69
▲(1.91% Upside)
Action:Reiterated
Date:08/18/26
The score is held down primarily by weak financial performance—declining revenue, sustained losses, and negative operating/free cash flow—despite a notably low-debt balance sheet. Technicals are only mildly supportive with mixed momentum and the price still below the 200-day average, while valuation is constrained by a negative P/E. A preferred-stock dividend declaration is a small positive but not a fundamental offset to earnings and cash-flow challenges.
Positive Factors
Very Low Leverage
Minimal debt reduces refinancing risk and interest-related pressure, giving the company more flexibility to manage operating volatility, fund production needs, or pursue recovery without relying heavily on new borrowing.
Negative Factors
Declining Revenue
Sustained revenue contraction signals weaker product demand, customer volumes, or competitive positioning. Lower sales can reduce manufacturing utilization and make it harder to absorb fixed costs, limiting the path to durable earnings improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Very Low Leverage
Minimal debt reduces refinancing risk and interest-related pressure, giving the company more flexibility to manage operating volatility, fund production needs, or pursue recovery without relying heavily on new borrowing.
Read all positive factors
Retractable Technologies (RVP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$20.96M
Dividend YieldN/A
Average Volume (3M)153.51K
Price to Earnings (P/E)―
Beta (1Y)0.35
Revenue Growth-11.16%
EPS Growth59.85%
CountryUS
Employees198
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.12
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Retractable Technologies Business Overview & Revenue Model
Company Description
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader ...
How the Company Makes Money
Retractable Technologies makes money primarily by selling medical devices—most notably safety syringes and related injection/collection products—to customers in the healthcare supply chain. Revenue is generated from product sales volumes and prici...
Retractable Technologies Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
72
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90M | 38.27M | 33.05M | 43.60M | 94.82M | 188.38M |
| Gross Profit | 392.99K | 47.05K | -1.03M | 9.11M | 28.25M | 95.35M |
| EBITDA | -5.36M | -4.42M | 4.17M | -1.24M | 9.94M | 76.44M |
| Net Income | -3.37M | -12.57M | -11.89M | -7.01M | 5.08M | 56.06M |
Balance Sheet | ||||||
| Total Assets | 141.69M | 142.63M | 160.72M | 179.67M | 210.74M | 213.15M |
| Cash, Cash Equivalents and Short-Term Investments | 39.87M | 36.97M | 44.56M | 47.29M | 49.38M | 42.43M |
| Total Debt | 715.92K | 895.64K | 1.23M | 1.54M | 2.92M | 4.24M |
| Total Liabilities | 68.83M | 68.26M | 73.55M | 80.38M | 104.21M | 113.98M |
| Stockholders Equity | 72.87M | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M |
Cash Flow | ||||||
| Free Cash Flow | -5.11M | -7.60M | -13.00M | 1.91M | -61.95K | -25.57M |
| Operating Cash Flow | -4.96M | -7.06M | -11.56M | 2.77M | 16.77M | 32.79M |
| Investing Cash Flow | 5.18M | 5.98M | 3.66M | -10.76M | -31.20M | -63.04M |
| Financing Cash Flow | -632.04K | -567.32K | -535.43K | 941.64K | 4.99M | 41.84M |
Retractable Technologies Technical Analysis
Positive
0.68
Price Trends
0.69
Positive
0.68
Positive
0.72
Positive
Market Momentum
<0.01
Negative
65.73
Neutral
78.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Positive. The current price of 0.68 is above the 20-day moving average (MA) of 0.68, below the 50-day MA of 0.69, and below the 200-day MA of 0.72, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 65.73 is Neutral, neither overbought nor oversold. The STOCH value of 78.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RVP.
Retractable Technologies Risk Analysis
Retractable Technologies disclosed 18 risk factors in its most recent earnings report. Retractable Technologies reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Retractable Technologies Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | $312.39M | -9.18 | -246.44% | ― | 12.93% | -219.19% | |
55 Neutral | $43.30M | -10.23 | -149.08% | ― | 3.72% | 43.78% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $262.77M | -5.45 | -21.50% | ― | -18.86% | -0.63% | |
48 Neutral | $20.96M | -5.94 | -8.45% | ― | -11.16% | 59.85% | |
46 Neutral | $139.28M | -5.63 | -145.82% | ― | -5.47% | 13.55% |
* Healthcare Sector Average
RVP
Retractable Technologies
0.72
-0.07
-9.32%
OSUR
Orasure Technologies
3.75
0.95
33.93%
STXS
Stereotaxis
1.36
-1.52
-52.78%
MLSS
Milestone Scientific
0.49
-0.11
-17.83%
SMTI
Sanara MedTech
34.17
3.31
10.73%
Retractable Technologies Corporate Events
Financial DisclosuresRegulatory Filings and Compliance
Retractable Technologies Reports Latest Quarterly Financial Results
Neutral
Aug 14, 2026
On August 14, 2026, Retractable Technologies announced its financial results for the periods ended June 30, 2026. The release of these results provides stakeholders with updated visibility into the company’s recent operating performance and ...
Dividends
Retractable Technologies Declares Dividend on Preferred Stock
Positive
Jun 30, 2026
On June 30, 2026, Retractable Technologies announced that its board declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The move underscores the company’s ongoing capital allocation to preferr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.